HCM vs TAK
HUTCHMED (China) Limited · Takeda Pharmaceutical Company Limited
Relative return (rebased to 100)
Key stats
| Metric | HCM | TAK |
|---|---|---|
| Price | $13.68 | $18.68 |
| Market Cap | $11.93B | $29.72B |
| P/E | 26.12 | — |
| P/B | 9.64 | — |
| P/S | 21.76 | — |
| ROE | 36.9% | — |
| Net Margin | 83.3% | — |
| Gross Margin | — | — |
| Revenue Growth | -13.0% | — |
| Dividend Yield | — | — |
| EPS | $0.52 | — |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.